Skip to main content
. 2020 Mar 18;12:45–56. doi: 10.2147/BCTT.S196240

Figure 1.

Figure 1

The molecular mechanism of action for Fulvestrant. Fulvestrant, being a pure steroidal ERα antagonist, inhibits the dimerization of the estrogen receptor and blocks the nuclear localization of the receptor itself. The binding of fulvestrant with ER also leads to a rapid degradation of the fulvestrant-ER complex and makes the receptor unavailable to estrogens, so the ability of ER to promote gene transcription is attenuated.